Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Aspirin in Cancer Patients with Stroke
NCT01763606Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2012
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin, aspirin in ischemic stroke, sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2012; status: completed.
02
Drugs
enoxaparinaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01763606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763606.